Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Brain Metabolite Changes in Subcortical Regions After Exposure to Cuprizone for 6 Weeks: Potential Implications for Schizophrenia.
Atorvastatin: Multiple Sclerosis.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers.
Human antigen R binding and regulation of SOX2 mRNA in human mesenchymal stem cells.
Environmental factors and their regulation of immunity in multiple sclerosis.
[The chronic form of tick-born encephalitis with a clinical manifestation of disseminated encephalomyelitis (case description).]
Multiple sclerosis imaging: recent advances.
[Anti-MOG antibody in different types of immune-mediated optic neuritis].
Acute Transverse Myelitis Associated With Human Parvovirus B19 Infection.
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
Ampyra for Optic Neuritis in MS
Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases.
The Gut Microbiome and the Brain.
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors.
Clinical characteristics of optic neuritis in koreans greater than 50 years of age.
Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.
Prolactin in multiple sclerosis.
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.
Magnetic susceptibility anisotropy: Cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
Pages
« first
‹ previous
…
292
293
294
295
296
297
298
299
300
…
next ›
last »